Abstract |
N-Acetylglucosaminyltransferase-V (GnT-V) has been reported to be up-regulated in invasive/metastatic cancer cells, but a comprehensive understanding of how the transferase correlates with the invasive/metastatic potential is not currently available. Through a glycomics approach, we identified 30 proteins, including tissue inhibitor of metalloproteinase-1 (TIMP-1), as a target protein for GnT-V in human colon cancer cell WiDr. TIMP-1 was aberrantly glycosylated as characterized by the addition of beta1,6-N-acetylglucosamine, polylactosaminylation, and sialylation in GnT-V-overexpressing WiDr cells. Compared with normal TIMP-1, the aberrantly glycosylated TIMP-1 showed the weaker inhibition on both matrix metalloproteinase (MMP)-2 and MMP-9, and this aberrancy was closely associated with cancer cell invasion and metastasis in vivo as well as in vitro. Integrated data, both of TIMP-1 expression level and aberrant glycosylation, could provide important information to aid to improve the clinical outcome of colon cancer patients.
|
Authors | Yong-Sam Kim, Soo Young Hwang, Hye-Yeon Kang, Hosung Sohn, Sejeong Oh, Jin-Young Kim, Jong Shin Yoo, Young Hwan Kim, Cheorl-Ho Kim, Jae-Heung Jeon, Jung Mi Lee, Hyun Ah Kang, Eiji Miyoshi, Naoyuki Taniguchi, Hyang-Sook Yoo, Jeong-Heon Ko |
Journal | Molecular & cellular proteomics : MCP
(Mol Cell Proteomics)
Vol. 7
Issue 1
Pg. 1-14
(Jan 2008)
ISSN: 1535-9476 [Print] United States |
PMID | 17878270
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Enzyme Inhibitors
- Mutant Proteins
- Neoplasm Proteins
- Tissue Inhibitor of Metalloproteinase-1
- N-Acetylglucosaminyltransferases
- alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferase
- Gelatinases
|
Topics |
- Cell Movement
(drug effects)
- Colonic Neoplasms
(enzymology, pathology)
- Disease Progression
- Electrophoresis, Gel, Two-Dimensional
- Enzyme Inhibitors
(pharmacology)
- Gelatinases
(antagonists & inhibitors)
- Glycosylation
(drug effects)
- HT29 Cells
- Humans
- Kinetics
- Mass Spectrometry
- Mutant Proteins
(metabolism)
- N-Acetylglucosaminyltransferases
(metabolism)
- Neoplasm Invasiveness
- Neoplasm Metastasis
- Neoplasm Proteins
(chemistry, metabolism)
- Protein Binding
(drug effects)
- Proteomics
(methods)
- Tissue Inhibitor of Metalloproteinase-1
(metabolism)
- Transfection
|